From the Departments of Neurology (Rubin, Dastgheyb) and Psychiatry and Behavioral Sciences (Rubin), Johns Hopkins University School of Medicine; Department of Epidemiology (Rubin, Springer), Johns Hopkins University Bloomberg School of Public Health; Department of Molecular and Cellular Pathobiology (Rubin), Johns Hopkins University School of Medicine, Baltimore, Maryland; Departments of Psychiatry (Maki, Steigman, Burke-Miller, Cook) and Psychology (Maki), University of Illinois at Chicago, Chicago, Illinois; Applied Mathematics and Statistics (Xu, Jin), Johns Hopkins University; Division of Biostatistics and Bioinformatics at The Sidney Kimmel Comprehensive Cancer Center (Xu), Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of General Internal Medicine (Sosanya), Montefiore Medical Center, Bronx; Department of Neurology (Gustafson), State University of New York Downstate Health Sciences University, Brooklyn, New York; Department of Medicine (Merenstein), Georgetown University Medical Center, Washington, DC; Department of Epidemiology and Biostatistics (Milam), University of California, Irvine, Irvine, California; and Cook County Health and Hospital System/Hektoen Institute of Medicine (Weber), Chicago, Illinois.
Address correspondence to Leah H. Rubin, PhD, MPH, Department of Neurology, Johns Hopkins University School of Medicine, 600 N. Wolfe St/Meyer 6-113, Baltimore, MD. E-mail: [email protected]
Received for publication September 28, 2022; revision received December 20, 2022.
Article Editor: David H. Chae
Supplemental Digital Content
